Advertisement

Topics

FDA panel votes in favor of Spark's blindness gene therapy

16:45 EDT 12 Oct 2017 | Reuters

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for...

Original Article: FDA panel votes in favor of Spark's blindness gene therapy

NEXT ARTICLE

More From BioPortfolio on "FDA panel votes in favor of Spark's blindness gene therapy"

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...